JNJ
173.89
+0.19%↑
ABBV
198.28
+0.11%↑
AZN
74.06
+0.64%↑
NVS
118.5
+1.46%↑
ABT
131.52
-2.16%↓
JNJ
173.89
+0.19%↑
ABBV
198.28
+0.11%↑
AZN
74.06
+0.64%↑
NVS
118.5
+1.46%↑
ABT
131.52
-2.16%↓
JNJ
173.89
+0.19%↑
ABBV
198.28
+0.11%↑
AZN
74.06
+0.64%↑
NVS
118.5
+1.46%↑
ABT
131.52
-2.16%↓
JNJ
173.89
+0.19%↑
ABBV
198.28
+0.11%↑
AZN
74.06
+0.64%↑
NVS
118.5
+1.46%↑
ABT
131.52
-2.16%↓
JNJ
173.89
+0.19%↑
ABBV
198.28
+0.11%↑
AZN
74.06
+0.64%↑
NVS
118.5
+1.46%↑
ABT
131.52
-2.16%↓
24h
Current
Min
7.77
Max
8.09
Income | -3.6M -50M |
---|---|
Sales | -476K 8.7M |
Profit margin | -580.17 |
Employees | 287 |
EBITDA | -5.1M -53M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +116.32% upside |
Market Cap | 120M 1.4B |
---|---|
Previous open | 8.2 |
Previous close | 8.08 |
By Trading Central
Confidence
Very Strong Bearish Evidence
6.35 / 6.555 Support & Resistance
Past performance is not a reliable indicator of future results.
11 Oct 2024, 15:56 UTC
GSK Bought More Shares of Biotech Wave Life Sciences -- Barrons.com
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 17.5 USD 116.32%
High 24 USD
Low 8.5 USD
Based on 14 Wall Street analysts offering 12 month price targets forWaVe Life Sciences Ltd - Dist in the last 3 months.
By TipRanks
Strong Buy
14 ratings
12
Buy
2
Hold
0
Sell
Based on 14 analysts giving stock ratings to WaVe Life Sciences Ltd - Dist in the past 3 months.
By Trading Central
Short Term
Very Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Bearish Evidence
All events are bearish.
Long Term
Bearish Evidence
Recent bearish events outweigh bullish events.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$